This smallcap hospital stock hits all-time high, jumps over 10%; here’s why

Shares of Yatharth Hospital & Trauma Care Services Ltd jumped over 10% on NSE to a record high of ₹839 on Tuesday, surpassing its previous peak of ₹819.60 touched on September 15, 2025.

As of 1:45 PM, the stock was trading at ₹826.70 on the BSE, up 8.56% even as the BSE Healthcare index dipped 0.2%.

The rally came after the Union Health Ministry announced revised rates for nearly 2,000 medical procedures under the Central Government Health Services (CGHS) scheme. The new rates, effective October 13,

introduce a multi-layered structure based on accreditation status and hospital type.

Consultations at NABH or NABL-accredited hospitals will be treated at a standard base rate, while non-accredited healthcare organisations will receive 15% lower rates. In contrast, super-speciality hospitals with over 200 beds will earn 15% higher than the base rate.

All CGHS-empanelled hospitals must accept the new terms by the deadline or seek fresh empanelment, reports said.

CGHS provides subsidised medical treatment to central government employees, pensioners, and their dependents at empanelled hospitals. The last major overhaul of CGHS rates was in 2014, with only minor revisions made since then. Currently, the scheme covers around 4.6 million beneficiaries across 80 cities in India.

Also Read: Yatharth Hospital aims to sustain 30% annual revenue growth for next 3-4 years

In its FY25 annual report, the company said India’s healthcare sector remains poised for growth, backed by an 11% increase in government allocation and policy support for infrastructure, research, and accessibility.

Yatharth Hospital recently reported a 40% year-on-year jump in net profit to ₹42 crore, while revenue rose 22% to ₹258 crore. EBITDA increased 20% to ₹65 crore, with margins steady at 25%.

Over the past year, Yatharth Hospital shares have rallied more than 55%, climbing from ₹534 to ₹839. According to reports, the stock continues to trade well above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, signalling strong upward momentum.